Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $8000.0.

  • Core Scientific's Other Non Operating Income fell 9966.09% to $8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year decrease of 36177.16%. This contributed to the annual value of -$487000.0 for FY2024, which is 10242.71% down from last year.
  • Latest data reveals that Core Scientific reported Other Non Operating Income of $8000.0 as of Q3 2025, which was down 9966.09% from -$1.4 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Other Non Operating Income peaked at $20.8 million during Q1 2023, and registered a low of -$8.0 million during Q2 2021.
  • Its 5-year average for Other Non Operating Income is $200333.3, with a median of -$208000.0 in 2022.
  • Per our database at Business Quant, Core Scientific's Other Non Operating Income tumbled by 3705000.0% in 2022 and then skyrocketed by 571540.62% in 2023.
  • Over the past 5 years, Core Scientific's Other Non Operating Income (Quarter) stood at $4000.0 in 2021, then plummeted by 5975.0% to -$235000.0 in 2022, then tumbled by 355.32% to -$1.1 million in 2023, then crashed by 125.51% to -$2.4 million in 2024, then skyrocketed by 100.33% to $8000.0 in 2025.
  • Its Other Non Operating Income was $8000.0 in Q3 2025, compared to -$1.4 million in Q2 2025 and -$157000.0 in Q1 2025.